Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4337 - 4344 of 11613 results
Investors Rush To File EB-5 Petitions Before Minimums Jump
November 20, 2019| News
Favorable Trends For Patent Owners Post-Aqua Products
November 20, 2019| News
A Victory for Digital Privacy Rights at the U.S. Border
November 19, 2019| Blog| Viewpoint
Former Senate Staffer Reveals How Congress Can Pass an Autonomous Vehicle Bill
November 19, 2019| News
Federal Judge Dismisses Claims Against Wynn Resorts Filed by Former Suffolk Downs Owner
November 18, 2019| News
CMS Finalizes Changes Expanding the Scope of the Open Payments Program
November 18, 2019| Blog| Viewpoint
Google Is Slurping Up Health Data—and It Looks Totally Legal
November 18, 2019| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.